糖尿病患者血脂管理及干预策略研究进展  

Research progress in lipid management and intervention strategies in diabetes patients

作　　者：赵静 徐帆 赵淑清[3] 夏瑜 余瑶[3] Zhao Jing;Xu Fan;Zhao Shuqing;Xia Yu;Yu Yao(General Practice Ward for Special Needs,West China Hospital/West China School of Nursing,Sichuan University,Chengdu 610041,China;School of Public Health,Chengdu Medical College,Chengdu 610500,China;Department of Dermatology and Venereology,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Emergency,Chengdu Jinjiang Hospital for Women and Children Health,Chengdu 610061,China)

机构地区：[1]四川大学华西医院全科(特需)病房/四川大学华西护理学院,成都610041 [2]成都医学院公共卫生学院,成都610500 [3]四川大学华西医院皮肤性病科,成都610041 [4]成都市锦江区妇幼保健院急诊科,成都610061

出　　处：《保健医学研究与实践》2024年第3期123-127,共5页Health Medicine Research and Practice

基　　金：四川省卫生健康委员会科研课题(20PJ171);成都市科技局重点研发支撑计划(2019-YF09-00097-SN)。

摘　　要：糖尿病(DM)患者常伴有血脂异常,这将增加心血管疾病的发病风险。降脂治疗、生活方式干预等能够显著改善DM患者的血脂异常状况,降低心血管事件的发生风险,从而让DM患者在临床上受益。本研究查阅相关文献,阐述了血脂管理及其干预策略的研究进展,旨在为临床治疗提供参考。Diabetes mellitus(DM)patients often exhibit dyslipidemia,which increases the risk of cardiovascular diseases.Lipid-lowering treatments and lifestyle interventions can markedly improve dyslipidemia in DM patients and reduce the risk of cardiovascular events,thereby providing clinical benefits for DM patients.This study reviews relevant literature and out-lines the research progress in lipid management and intervention strategies,aiming to provide a reference for clinical treat-ment.

关 键 词：糖尿病 血脂管理 干预策略 他汀类药物 低密度脂蛋白胆固醇 甘油三酯 总胆固醇 

分 类 号：R587.1[医药卫生—内分泌]